Q9H6Z4 (RANB3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ran-binding protein 3 Short name=RanBP3 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 567 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts as a cofactor for XPO1/CRM1-mediated nuclear export, perhaps as export complex scaffolding protein. Bound to XPO1/CRM1, stabilizes the XPO1/CRM1-cargo interaction. In the absence of Ran-bound GTP prevents binding of XPO1/CRM1 to the nuclear pore complex. Binds to CHC1/RCC1 and increases the guanine nucleotide exchange activity of CHC1/RCC1. Recruits XPO1/CRM1 to CHC1/RCC1 in a Ran-dependent manner. Negative regulator of TGF-beta signaling through interaction with the R-SMAD proteins, SMAD2 and SMAD3, and mediating their nuclear export. Ref.1 Ref.6 Ref.7 Ref.8 Ref.12 |
| Subunit structure | Interacts with CHC1 in a Ran-stimulated manner. Interacts with XPO1. Interacts (via its C-terminal R domain) with SMAD2 (dephosphorylated form via its MH1 and MH2 domains); the interaction results in the nuclear export of SMAD2 and termination of the TGF-beta signaling. Interacts (via its C-terminal R domain) with SMAD3 (dephosphorylated form via its MH1 domain); the interaction results in the nuclear export of SMAD3 and termination of the TGF-beta signaling. Ref.1 Ref.6 Ref.7 Ref.8 Ref.12 |
| Subcellular location | |
| Tissue specificity | Widely expressed with high levels in testis and heart. Ref.1 |
| Sequence similarities | Contains 1 RanBD1 domain. |
| Sequence caution | The sequence AAH04349.1 differs from that shown. Reason: Aberrant splicing. The sequence CAB43293.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Protein transport Transport |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | intracellular transport Inferred from electronic annotation. Source: InterPro protein transportInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from direct assay. Source: LIFEdb |
| Molecular_function | Ran GTPase binding Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| RCC1 | P18754 | 2 | EBI-992681,EBI-992720 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9H6Z4-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9H6Z4-2) Also known as: Ranbp3-a; The sequence of this isoform differs from the canonical sequence as follows: 226-230: Missing. | ||||||
| Isoform 3 (identifier: Q9H6Z4-3) Also known as: Ranbp3-b; The sequence of this isoform differs from the canonical sequence as follows: 27-94: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 567 | 567 | Ran-binding protein 3 | PRO_0000097165 | ||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||
| Domain | 378 – 518 | 141 | RanBD1 | |||||||||||||||||||||||||||
| Compositional bias | 76 – 81 | 6 | Poly-Pro | |||||||||||||||||||||||||||
| Compositional bias | 537 – 543 | 7 | Poly-Asp | |||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||
| Modified residue | 21 | 1 | N6-acetyllysine Ref.14 | |||||||||||||||||||||||||||
| Modified residue | 100 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 101 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 108 | 1 | Phosphoserine Ref.9 Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 115 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||||
| Modified residue | 124 | 1 | Phosphothreonine Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 219 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||
| Modified residue | 221 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||||
| Modified residue | 333 | 1 | Phosphoserine Ref.11 Ref.13 Ref.17 | |||||||||||||||||||||||||||
| Modified residue | 353 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 355 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||
| Modified residue | 539 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||
| Alternative sequence | 27 – 94 | 68 | Missing in isoform 3. | VSP_011163 | ||||||||||||||||||||||||||
| Alternative sequence | 226 – 230 | 5 | Missing in isoform 2. | VSP_011162 | ||||||||||||||||||||||||||
| Natural variant | 314 | 1 | A → V. Corresponds to variant rs10417885 [ dbSNP | Ensembl ]. | VAR_051303 | ||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||
| Sequence conflict | 358 – 359 | 2 | SS → PF in CAA69956. Ref.1 | |||||||||||||||||||||||||||
| Sequence conflict | 367 | 1 | E → G in CAA69957. Ref.1 | |||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||
| Turn | 389 – 391 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 399 – 412 | 14 | ||||||||||||||||||||||||||||
| Turn | 413 – 416 | 4 | ||||||||||||||||||||||||||||
| Beta strand | 417 – 432 | 16 | ||||||||||||||||||||||||||||
| Turn | 434 – 436 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 439 – 447 | 9 | ||||||||||||||||||||||||||||
| Turn | 448 – 450 | 3 | ||||||||||||||||||||||||||||
| Beta strand | 453 – 458 | 6 | ||||||||||||||||||||||||||||
| Beta strand | 465 – 469 | 5 | ||||||||||||||||||||||||||||
| Beta strand | 472 – 476 | 5 | ||||||||||||||||||||||||||||
| Beta strand | 487 – 491 | 5 | ||||||||||||||||||||||||||||
| Helix | 494 – 519 | 26 | ||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human RanBP3, a group of nuclear RanGTP binding proteins." Mueller L., Cordes V.C., Bischoff F.R., Ponstingl H. FEBS Lett. 427:330-336(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH CHC1. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3). Tissue: Colon and Testis. |
| [3] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Uterus. |
| [4] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-418 (ISOFORM 3). Tissue: Eye. |
| [6] | "RanBP3 influences interactions between CRM1 and its nuclear protein export substrates." Englmeier L., Fornerod M., Bischoff F.R., Petosa C., Mattaj I.W., Kutay U. EMBO Rep. 2:926-932(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH XPO1. |
| [7] | "Ran-binding protein 3 is a cofactor for Crm1-mediated nuclear protein export." Lindsay M.E., Holaska J.M., Welch K., Paschal B.M., Macara I.G. J. Cell Biol. 153:1391-1402(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH XPO1. |
| [8] | "Ran-binding protein 3 links Crm1 to the Ran guanine nucleotide exchange factor." Nemergut M.E., Lindsay M.E., Brownawell A.M., Macara I.G. J. Biol. Chem. 277:17385-17388(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CHC1. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-101; SER-108; THR-124; SER-333; SER-353; SER-355 AND SER-539, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling." Dai F., Lin X., Chang C., Feng X.H. Dev. Cell 16:345-357(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SMAD2 AND SMAD3, SUBCELLULAR LOCATION, FUNCTION. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, MASS SPECTROMETRY. |
| [18] | "Solution structure of the RAN_BP1 domain of RAN-binding protein-3." RIKEN structural genomics initiative (RSGI) Submitted (NOV-2005) to the PDB data bank Cited for: STRUCTURE BY NMR OF 380-516. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | Y08697 mRNA. Translation: CAA69956.1. Y08698 mRNA. Translation: CAA69957.1. AK025300 mRNA. Translation: BAB15106.1. AK314343 mRNA. Translation: BAG36985.1. AL050149 mRNA. Translation: CAB43293.1. Different initiation. AC004602 Genomic DNA. Translation: AAC14485.1. AC104532 Genomic DNA. No translation available. AC093050 Genomic DNA. No translation available. AC005784 Genomic DNA. No translation available. BC004349 mRNA. Translation: AAH04349.1. Sequence problems. | ||||||||||||||||||||||||
| IPI | IPI00026337. IPI00179121. IPI00456728. IPI00456729. | ||||||||||||||||||||||||
| PIR | T08778. | ||||||||||||||||||||||||
| RefSeq | NP_003615.2. NM_003624.2. NP_015559.2. NM_007320.2. NP_015561.1. NM_007322.2. | ||||||||||||||||||||||||
| UniGene | Hs.531752. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q9H6Z4. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | Q9H6Z4. 4 interactions. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000341483. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q9H6Z4. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 51316528. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | Q9H6Z4. | ||||||||||||||||||||||||
| PeptideAtlas | Q9H6Z4. | ||||||||||||||||||||||||
| PRIDE | Q9H6Z4. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000034275; ENSP00000034275; ENSG00000031823. ENST00000340578; ENSP00000341483; ENSG00000031823. ENST00000439268; ENSP00000404837; ENSG00000031823. | ||||||||||||||||||||||||
| GeneID | 8498. | ||||||||||||||||||||||||
| KEGG | hsa:8498. | ||||||||||||||||||||||||
| UCSC | uc002mdv.3. human. uc002mdx.3. human. uc002mdy.3. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 8498. | ||||||||||||||||||||||||
| GeneCards | GC19M005916. | ||||||||||||||||||||||||
| HGNC | HGNC:9850. RANBP3. | ||||||||||||||||||||||||
| HPA | HPA043375. HPA043389. | ||||||||||||||||||||||||
| MIM | 603327. gene. | ||||||||||||||||||||||||
| neXtProt | NX_Q9H6Z4. | ||||||||||||||||||||||||
| PharmGKB | PA34211. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG304969. | ||||||||||||||||||||||||
| HOVERGEN | HBG061383. | ||||||||||||||||||||||||
| InParanoid | Q9H6Z4. | ||||||||||||||||||||||||
| KO | K15304. | ||||||||||||||||||||||||
| OMA | EQEAKMP. | ||||||||||||||||||||||||
| PhylomeDB | Q9H6Z4. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | wnt_canonical_pathway. Canonical Wnt signaling pathway. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q9H6Z4. | ||||||||||||||||||||||||
| Bgee | Q9H6Z4. | ||||||||||||||||||||||||
| CleanEx | HS_RANBP3. | ||||||||||||||||||||||||
| Genevestigator | Q9H6Z4. | ||||||||||||||||||||||||
| GermOnline | ENSG00000031823. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 2.30.29.30. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR011993. PH_like_dom. IPR000156. Ran_bind_dom. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00638. Ran_BP1. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SMART | SM00160. RanBD. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50196. RANBD1. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| ChiTaRS | RANBP3. human. | ||||||||||||||||||||||||
| EvolutionaryTrace | Q9H6Z4. | ||||||||||||||||||||||||
| GenomeRNAi | 8498. | ||||||||||||||||||||||||
| NextBio | 31793. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | RANB3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9H6Z4 Secondary accession number(s): B2RAT8 Q9UG74 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
